Hema Metrics for Dry weight, fluid overload and management, Blood Volume monitoring and improved dialysis treatment and Prevention of hypovolemia
News & Information
HEMA METRICS ANNOUNCES RICHARD GANZ HAS JOINED ITS BOARD OF DIRECTORS.
HEMA METRICS ANNOUNCES NEW ARTICLE VALIDATING THAT MORE FREQUENT HAEMOGLOBIN MONITORING REDUCES HAEMOGLOBIN VARIABILITY
Crit-Line Takes the Guesswork out of Removing Fluid from the Dialysis Patient
Anne Diroll interview - Anne answers queries over a wide range of Dialysis topics
View All News & Information
Press Release
 
 
HEMA METRICS' CRIT-LINEŽ TECHNOLOGY NOW AVAILABLE IN THE CHF SOLUTIONS' AQUADEX FLEXFLOWTM DEVICE
 
Date: June 30, 2009
 
FROM:
HEMA METRICS LLC
695 North 900 West
Kaysville, Utah 84037
CONTACT: Patrick Moriarty, President/CEO
(801) 451-9000 Ext. 103
pmoriarty@hemametrics.com

CHF Solutions Inc.
7601 Northland Dr. Suite 170
Brooklyn Park, MN 55428
CONTACT: Dave Springer,
President/CEO
(763) 463-4600
dspringer@chfsolutions.com

SALT LAKE CITY, UTAH and BROOKLYN PARK, MINN. June 30, 2009

Hema Metrics and CHF Solutions jointly announced today that the Hema Metrics Crit-Line technology is now available in the Aquadex FlexFlow Device manufactured by CHF Solutions Inc.

The Aquadex FlexFlow is used to deliver AquapheresisTM therapy, a safe, predictable, and effective method to remove excess salt and water from patients with fluid overload. Recently elevated in treatment guidleines, Aquapheresis is available in over 250 medical centers and outpatient clinics worldwide and more than 22,000 patients have received this therapy to date.

The integrated Crit-Line technology, called CRIT-SATTM, allows for the non-invasive measurement of hematocrit and oxygen saturation during the Aquaphersesis fluid removal process. This additional information provides an early window on each individual patient's hemodynamic response and helps ensure that the most appropriate fluid removal is achieved.

"Hematocrit monitoring with Aquaphersis provides enhanced peace-of-mind and further empowers healthcare professionals in their continuing efforts to achieve the guideline-directed treatment goal of euvolemia in fluid overloaded patients", said Dave Springer, President and CEO of CHF Solutions.

"Hema Metrics is pleased to have joined forces with CHF Solutions" said Patrick Moriarty, President and CEO of Hema Metrics. "We have always believed the Crit-Line technology could be very useful in the treatment patients with fluid overload. Having the Crit-Line technology more readily available in the hospital setting will open more markets for Hema Metrics."

About Hema Metrics LLC
Hema Metrics LLC. provides diagnostic products for the hemodialysis market. Hema Metrics manufactures, markets and distributes the "CRIT-LINEŽ" system. The monitoring and diagnostic capability of the CRIT-LINEŽ technology provides better clinical outcomes and lower overall costs and improved quality of life for dialysis patients. For more information, visit www.hemametrics.com

About CHF Solutions, Inc.
CHF Solutions, based in Brooklyn Park, Minn., is a privately held manufacturer of medical devices for cardiac care. The company's mission is to provide medical practitioners with innovative and practical solutions that enable the treatment of patients with unmet clinical needs. For more information, go to www.chfsolutions.com